Novavax

Færslur: Novavax

epa09045943 A handout photo made available by the Presidential press service of Ukraine shows Ukrainian President Volodymyr Zelensky receiving an injection with the AstraZeneca (Covishield) vaccine in a Military Mobile Hospital during his visit to the Eastern-Ukrainian conflict zone in Luhansk area, Ukraine, 02 March 2021. Ukraine started vaccination against COVID-19 on 24 February 2021. The first shipment of the Oxford/AstraZeneca (Covishield) vaccine against COVID-19 was delivered in Ukraine on 23 February. Ukraine has signed a contract for the supply of 12 million doses of COVID-19 vaccines, which were developed by AstraZeneca (UK-Sweden) and NovaVax (USA) and are produced at the Serum Institute facilities (India). EPA-EFE/PRSIDENTIAL PRESS SERVICE OF UKRAINE HANDOUT HANDOUT HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES

Lyfjastofnun Evrópu tekur ákvörðun um Novavax í dag

Lyfjastofnun Evrópu tekur ákvörðun um það í dag hvort heimila eigi notkun Covid-bóluefnis bandaríska lyfjafyrirtækisins Novavax. Aukafundur lyfjanefndar verður haldinn um málið og niðurstöður kynntar strax að honum loknum.

20.12.2021 - 05:22

epa08954953 Syringes with vaccine against Covid-19 are prepared at the vaccination centre in Giessen, Germany, 21 January 2021. EPA-EFE/OLIVER VOGLER / POOL

COVAX pantar 350 milljón skammta af bóluefni Novavax

COVAX-samstarfið, alþjóðlega bólusetningarátakið gegn COVID-19, hefur samið um kaup á 350 milljónum skammta af bóluefni bandaríska líftæknifyrirtækisins Novavax.

06.05.2021 - 23:14

Erlent · Heilbrigðismál · Tækni og vísindi · Bóluefni gegn COVID-19 · Novavax · COVAX · Breska afbrigðið · COVID-19

Beint sjónvarp og útvarp

Færslur: Novavax

Mest lesið